{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:04:51Z","timestamp":1791849891168,"version":"4.3.4"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Diabetes mellitus is the most common endocrinological disease associated with different life-threatening infections. Urinary Tract Infection is one of them which may lead to Intensive care Unit admission and even death. In this study, we would like to find out the spectrum of uropathogen and its antibiotic sensitivity, so that we can choose empirical antibiotics early to save lives.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim and Objectives:<\/jats:title>\n                    <jats:p>To find out spectrum of uropathogens in Diabetic patients attending to Diabetes Clinic of a tertiary hospital and to find out the Antibiotic sensitivity pattern in isolated bacteria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Material and Methods:<\/jats:title>\n                    <jats:p>In this cross-sectional observational hospital-based study, consecutive patients of any age and gender having Diabetes mellitus and symptoms of Urinary Tract Infection, who attended Out-patient Department and Diabetes Clinic of General Medicine Department from August 2020 to October 2020, were included. After taking consent and brief history, mid-stream clean catch urine sample was collected in sterile container and sent to a Microbiology laboratory for culture of micro-organism and sensitivity to antibiotics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Among 202 diabetic patients recruited in our study, 138 (68.31%) were female and 64 (31.69%) were male. The mean age of all participants was 50.23 \u00b1 11.45 years. Culture confirmed UTI was 24.3% and patients showing classic UTI symptoms were 32.7%. Compared to male, most of the culture-positive and symptomatic patients were female (26.0% and 37% respectively). Culture-positive patients who showed classic UTI symptoms were 42.42%; however, we found 15.44% asymptomatic patients who showed culture positivity. The mean HbA1c level was 7.5 \u00b1 1.6%. Subgroup analysis revealed that patients with HbA1c &gt;7.5% were at a significantly higher risk of developing culture-positive UTI (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.00001, Odds ratio 21.71). Prevalence of gram-negative and gram-positive bacteria were 65.3% (32 out of 49) and 28.57% (14 out of 49), respectively. The major organism isolated were\n                      <jats:italic toggle=\"yes\">Escherichia coli<\/jats:italic>\n                      (39%),\n                      <jats:italic toggle=\"yes\">Klebsiella spp<\/jats:italic>\n                      . (19%),\n                      <jats:italic toggle=\"yes\">Enterococcus spp<\/jats:italic>\n                      . (12%),\n                      <jats:italic toggle=\"yes\">Staphylococcus aureus<\/jats:italic>\n                      (12%), and\n                      <jats:italic toggle=\"yes\">Candida spp<\/jats:italic>\n                      . (6%). The sensitivity pattern of the gram-negative bacilli showed the presence of Extended-spectrum betalactamases (ESBLs) in 36.84% (11 out of 32 isolates). The bacteria grown were most sensitive to Piperacillin-tazobactam (100%), Cefoperazone-sulbactam (100%) and Meropenem (100%) whereas Fluoroquinolone and Co-Amoxyclav showed least sensitivity (43.8% and 37.5% respectively). The Staphylococcus spp. showed 100% sensitivity to Vancomycin, Teicoplanin, Linezolid whereas Penicillin-G and Ampicillin showed 12.5% sensitivity. The Enterococcus spp. revealed 100% sensitivity to Vancomycin, Teicoplanin, Linezolid, and Fosfomycin. Drug resistance is emerging in clinical isolates. Prevalence of ESBL in Enterobacteriacea was found to be 34%.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>All patients with diabetes must be searched for urinary tract bacterial colonization by simple routine urinary culture even though they are asymptomatic. Resistance to common antibiotics, particularly to oral formulations (especially Fluoroquinolones and Ampicillin) is increasing day by day due to indiscriminate use of antibiotics. This study highlighted that the policy makers should formulate antibiotic policy for rational use of antibiotics, which could help clinicians to prescribe proper antibiotics. However, regular monitoring of susceptibility pattern of urinary pathogens is essential.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jfmpc.jfmpc_71_21","type":"journal-article","created":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T13:07:59Z","timestamp":1637327279000},"page":"3638-3643","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":14,"title":["Pattern of uropathogens and antibiotic sensitivity in diabetes patients attending to out \u2013 Patient department and diabetes clinic of a teaching hospital"],"prefix":"10.4103","volume":"10","author":[{"given":"Tanusree","family":"Nath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somak Kumar","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santanu","family":"Hazra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-19-20240828","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S2213-8587(17)30174-2","article-title":"Prevalence of diabetes and prediabetes in 15 states of India:Results from the ICMR-INDIAB population-based cross-sectional study","volume":"5","author":"Anjana","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R2-19-20240828","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/ijem.IJEM_225_20","article-title":"RSSDI-ESI clinical practice recommendations for the management of type 2 diabetes mellitus 2020","volume":"24","author":"Chawla","year":"2020","journal-title":"Indian J Endocr Metab"},{"key":"R3-19-20240828","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.dsx.2018.05.016","article-title":"High prevalence of diabetes, prediabetes and obesity among residents of East Delhi \u2013The Delhi urban diabetes survey (DUDS)","volume":"12","author":"Madhu","year":"2018","journal-title":"Diabetes Metab Syndr"},{"key":"R4-19-20240828","doi-asserted-by":"crossref","first-page":"6573215","DOI":"10.1155\/2016\/6573215","article-title":"Prevalence of urinary tract infection and antimicrobial susceptibility among diabetic patients with controlled and uncontrolled glycemia in Kuwait","volume":"2016","author":"Sewify","year":"2016","journal-title":"J Diabetes Res"},{"key":"R5-19-20240828","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.12669\/pjms.36.7.2881","article-title":"Diabetes mellitus and urinary tract infection:Causative uropathogens, their antibiotic susceptibility pattern and the effects of glycemic status","volume":"36","author":"Ahmad","year":"2020","journal-title":"Pak J Med Sci"},{"key":"R6-19-20240828","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.12669\/pjms.35.6.115","article-title":"Frequency of urinary tract infection and antibiotic sensitivity of uropathogens in patients with diabetes","volume":"35","author":"Zubair","year":"2019","journal-title":"Pak J Med Sci"},{"key":"R7-19-20240828","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.2147\/DMSO.S262760","article-title":"Bacterial profiles and their associated factors of urinary tract infection and detection of extended spectrum beta-lactamase producing gram-negative uropathogens among patients with diabetes mellitus at Dessie Referral Hospital, Northeastern Ethiopia","volume":"13","author":"Alemu","year":"2020","journal-title":"Diabetes Metab Syndr Obes"},{"key":"R8-19-20240828","doi-asserted-by":"crossref","first-page":"20","DOI":"10.7326\/0003-4819-142-1-200501040-00008","article-title":"Risk factors associated with acute pyelonephritis in healthy women","volume":"142","author":"Scholes","year":"2005","journal-title":"Ann Intern Med"},{"key":"R9-19-20240828","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3126\/jmmihs.v1i4.11998","article-title":"Diabetes mellitus and urinary tract infection:Spectrum of uropathogens and their antibiotic sensitivity","volume":"1","author":"Acharya","year":"2015","journal-title":"J Manmohan Mem Inst Health Sci"},{"key":"R10-19-20240828","first-page":"226","article-title":"Prevalence of uropathogens and their antibiogram in diabetic patients a cross sectional study","volume":"4","author":"Sarvepalli","year":"2015","journal-title":"Int J Curr Microbiol App Sci"},{"key":"R11-19-20240828","first-page":"26","article-title":"Prevalence of uropathogens in diabetic patients and their antimicrobial susceptibility pattern","volume":"1","author":"Sharma","year":"2012","journal-title":"Natl J lab Med"},{"key":"R12-19-20240828","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s00203-020-01818-x","article-title":"Diabetes-associated infections:Development of antimicrobial resistance and possible treatment strategies","volume":"202","author":"Akash","year":"2020","journal-title":"Arch Microbiol"},{"key":"R13-19-20240828","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4103\/0971-4065.57107","article-title":"Prevalence of lower urinary tract infection in South Indian type 2 diabetic subjects","volume":"19","author":"Janifer","year":"2009","journal-title":"Indian J Nephrol"},{"key":"R14-19-20240828","first-page":"1","article-title":"Urinary tract infection and antibiotic sensitivity pattern among diabetics","volume":"15","author":"Simkhada","year":"2013","journal-title":"Nepal Med Coll J"},{"key":"R15-19-20240828","first-page":"29","article-title":"Prevalence of uropathogens in diabetic patients and their susceptibility pattern at a Tertiary care center in Nepal-A retrospective study","volume":"3","author":"Jha","year":"2014","journal-title":"Int J Biomed Lab Sci"},{"key":"R16-19-20240828","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12941-015-0082-4","article-title":"Urinary tract infections and antimicrobial sensitivity among diabetic patients at Khartoum, Sudan","volume":"14","author":"Hamdan","year":"2015","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"R17-19-20240828","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jdiacomp.2012.06.008","article-title":"Incidence of urinary tract infection among patients with type 2 diabetes in the UK General practice research database (GPRD)","volume":"26","author":"Hirji","year":"2012","journal-title":"J Diabetes Complications"},{"key":"R18-19-20240828","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4066\/AMJ.2014.1906","article-title":"Clinical profile of urinary tract infections in diabetics and non-diabetics","volume":"7","author":"Aswani","year":"2014","journal-title":"Australas Med J"},{"key":"R19-19-20240828","first-page":"14","article-title":"Urinary tract infection in elderly:Clinical profile and outcome","volume":"66","author":"Kakde","year":"2018","journal-title":"J Assoc Physicians India"},{"key":"R20-19-20240828","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.2147\/IDR.S298176","article-title":"Prevalence of bacterial urinary tract infection and antimicrobial susceptibility patterns among diabetes mellitus patients attending Zewditu memorial hospital, Addis Ababa, Ethiopia","volume":"14","author":"Yenehun Worku","year":"2021","journal-title":"Infect Drug Resist"},{"key":"R21-19-20240828","first-page":"97","article-title":"Clinico-microbiological profile of urinary tract infections in diabetic patients in Tertiary centre in Kerala","volume":"9","author":"Prabhu","year":"2016","journal-title":"Kerala Med J"},{"key":"R22-19-20240828","first-page":"e13837","article-title":"Increased isolation of extended-spectrum beta-lactamase-producing Escherichia coli from community-onset urinary tract infection cases in Uttarakhand, India","volume":"13","author":"Kumar","year":"2021","journal-title":"Cureus"}],"container-title":["Journal of Family Medicine and Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_71_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:12:13Z","timestamp":1787771533000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_71_21"}},"subtitle":["A cross-sectional study"],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":22,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_71_21","relation":{},"ISSN":["2249-4863"],"issn-type":[{"value":"2249-4863","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]}}}